Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$1.31B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.17B |
| 3 |
Privia Health
PRVA
|
+$1.13B |
| 4 |
GRUB
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
|
+$1.01B |
| 5 |
Sea Limited
SE
|
+$852M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$960M |
| 2 |
Avantor
AVTR
|
+$895M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$760M |
| 4 |
State Street SPDR S&P Biotech ETF
XBI
|
+$645M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$640M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.59% |
| 2 | Consumer Discretionary | 9.73% |
| 3 | Financials | 8.55% |
| 4 | Healthcare | 8.03% |
| 5 | Communication Services | 6.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MBAC
3351
DELISTED
M3-Brigade Acquisition II Corp.
MBAC
| $4.63M | ﹤0.01% |
+476,461
| New | +$4.64M |
|
|
SLAM
3352
DELISTED
Slam Corp. Class A Ordinary Share
SLAM
| $4.63M | ﹤0.01% |
+477,353
| New | +$4.66M |
|
3353
PUT
Seagate
STX
$190B
| $4.62M | ﹤0.01% |
52,500
+21,900
| +72% | +$1.97M |
|
|
BOAC
3354
DELISTED
Bluescape Opportunities Acquisition Corp.
BOAC
| $4.61M | ﹤0.01% |
470,234
+295,910
| +170% | +$2.93M |
|
|
CMO
3355
DELISTED
Capstead Mortgage Corp.
CMO
| $4.61M | ﹤0.01% |
751,140
+5,934
| +0.8% | +$38.3K |
|
|
CND
3356
DELISTED
Concord Acquisition Corp.
CND
| $4.61M | ﹤0.01% |
468,037
+133,286
| +40% | +$1.31M |
|
3357
Diamondrock Hospitality Co
DRH
$2.71B
| $4.61M | ﹤0.01% |
474,998
-19,212
| -4% | -$193K |
|
3358
Cue Biopharma
CUE
$112M
| $4.6M | ﹤0.01% |
13,155
-6,915
| -34% | -$2.68M |
|
3359
PUT
AB InBev
BUD
$168B
| $4.59M | ﹤0.01% |
63,800
+55,100
| +633% | +$4.02M |
|
3360
Stoke Therapeutics
STOK
$1.99B
| $4.59M | ﹤0.01% |
136,388
-421,985
| -76% | -$14.9M |
|
|
EPZM
3361
DELISTED
Epizyme, Inc
EPZM
| $4.59M | ﹤0.01% |
552,342
-159,618
| -22% | -$1.35M |
|
|
RDUS
3362
DELISTED
Radius Recycling
RDUS
| $4.59M | ﹤0.01% |
93,555
-13,915
| -13% | -$692K |
|
|
TMTS
3363
DELISTED
Spartacus Acquisition Corporation Class A Common Stock
TMTS
| $4.58M | ﹤0.01% |
455,670
+44,000
| +11% | +$439K |
|
|
SLCA
3364
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $4.57M | ﹤0.01% |
395,057
+203,135
| +106% | +$2.36M |
|
3365
Invesco China Technology ETF
CQQQ
$3.16B
| $4.55M | ﹤0.01% |
54,027
| – | – |
|
|
SAND
3366
DELISTED
Sandstorm Gold
SAND
| $4.54M | ﹤0.01% |
575,117
+13,467
| +2% | +$109K |
|
|
LKFT
3367
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.71B
| $4.54M | ﹤0.01% |
65,844
-194,243
| -75% | -$14.8M |
|
3368
The Greenbrier Companies
GBX
$1.54B
| $4.53M | ﹤0.01% |
103,916
+32,487
| +45% | +$1.5M |
|
3369
Douglas Dynamics
PLOW
$1.06B
| $4.52M | ﹤0.01% |
111,145
+62,390
| +128% | +$2.74M |
|
|
CNVY
3370
DELISTED
Convey Health Solutions Holdings, Inc.
CNVY
| $4.52M | ﹤0.01% |
+397,355
| New | +$4.6M |
|
|
ACB
3371
PUT
Aurora Cannabis
ACB
$180M
| $4.52M | ﹤0.01% |
+50,000
| New | +$4.33M |
|
3372
TechTarget
TTGT
$321M
| $4.51M | ﹤0.01% |
58,184
-31,811
| -35% | -$2.28M |
|
3373
iShares MSCI Poland ETF
EPOL
$747M
| $4.49M | ﹤0.01% |
209,205
| – | – |
|
3374
Zentalis Pharmaceuticals
ZNTL
$352M
| $4.48M | ﹤0.01% |
84,289
+32,480
| +63% | +$1.74M |
|
3375
PUT
Cigna
CI
$71.5B
| $4.48M | ﹤0.01% |
18,900
-300
| -2% | -$74.9K |
|
Similar funds
Goldman Sachs's Q2 2021 Portfolio in Review
As of Q2 2021, Goldman Sachs held 6,869 positions worth $446B, up 13% from $396B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Goldman Sachs deployed $20.1B of net new capital in Q2 2021, opening 820 new positions and adding to 2,556 existing holdings. Its largest new stake was Privia Health: 30,513,629 shares worth $1.35B.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $960M trimmed.
- Goldman Sachs's largest Q2 2021 buy was Privia Health: 30,513,629 shares worth $1.35B.
- Goldman Sachs added most to Alibaba in Q2 2021, an estimated $1.31B increase.
- Goldman Sachs's biggest Q2 2021 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $960M.
- Goldman Sachs fully exited Pluralsight, Inc. Class A Common Stock in Q2 2021, selling an estimated $128M.
- Goldman Sachs's ten largest holdings make up 17% of its $446B portfolio in Q2 2021.
- Goldman Sachs opened 820 new positions and closed 700 in Q2 2021.
- Goldman Sachs's portfolio value rose 13% quarter-over-quarter to $446B.
Based on Goldman Sachs's 13F filing for Q2 2021, filed 13 Aug 2021.